XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net income $ 34,218 $ 43,291
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 7,302 7,146
Bad debt provision 6,709 5,921
Deferred income tax benefit 0 (3,923)
Share-based compensation expense 4,569 3,925
Amortization of premium on marketable securities 1,138 950
Unrealized gain on deferred compensation fund investments (4,053) (961)
Loss on sale of assets 597 0
Changes in operating assets and liabilities:    
Accounts and notes receivable (23,054) 2,635
Inventories and supplies 3,578 2,840
Prepaid expenses and other assets (19,972) (3,931)
Deferred compensation funding 444 990
Accounts payable and other accrued expenses 17,827 (964)
Accrued payroll, accrued and withheld payroll taxes (10,088) 16,104
Income taxes payable 2,595 12,847
Accrued insurance claims 2,945 5,396
Deferred compensation liability 4,087 117
Net cash provided by operating activities 28,842 92,383
Cash flows from investing activities:    
Disposals of fixed assets 84 307
Additions to property and equipment (2,093) (1,835)
Purchases of marketable securities (15,138) (6,939)
Sales of marketable securities 12,031 5,779
Cash paid for acquisition (6,000) 0
Net cash used in investing activities (11,116) (2,688)
Cash flows from financing activities:    
Dividends paid (31,034) (30,161)
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan 46 45
Proceeds from the exercise of stock options 1,855 1,862
Purchases of treasury stock (1,835) 0
Repayments of short-term borrowings 0 (10,000)
Payments of statutory withholding on net issuance of restricted stock units (1,501) (661)
Net cash used in financing activities (32,469) (38,915)
Net change in cash and cash equivalents (14,743) 50,780
Cash and cash equivalents at beginning of the period 139,330 27,329
Cash and cash equivalents at end of the period 124,587 78,109
Supplemental disclosure of non-cash investing activities    
Accrued variable consideration from acquisition of a business $ 5,703 $ 0